BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+5.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$531M
AUM Growth
+$531M
(-3.6%)
Cap. Flow
-$34.6M
Cap. Flow
% of AUM
-6.51%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
139
New
9
Increased
20
Reduced
40
Closed
15
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$8.11M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$6.25M |
| 3 |
Stryker
SYK
|
$6.23M |
| 4 |
AMSG
Amsurg Corp
AMSG
|
$5.74M |
| 5 |
Hologic
HOLX
|
$5.44M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$6.99M |
| 2 |
Gilead Sciences
GILD
|
$6.41M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$5.64M |
| 4 |
Biogen
BIIB
|
$5.33M |
| 5 |
STJ
St Jude Medical
STJ
|
$4.84M |
Sector Composition
| 1 | Healthcare | 92.67% |
| 2 | Financials | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $24.5M | 4.61% | 282,500 +6,000 | +2% | +$521K |
|
|
2
Stryker
SYK
$150B
| $21.2M | 3.99% | 177,000 +52,000 | +42% | +$6.23M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $19.3M | 3.64% | 196,050 -14,500 | -7% | -$1.43M |
|
4
Abbott
ABT
$231B
| $15M | 2.82% | 381,500 | – | – |
|
5
Cardinal Health
CAH
$35.5B
| $14.7M | 2.77% | 188,780 +29,150 | +18% | +$2.27M |
|
6
UnitedHealth
UNH
$281B
| $14M | 2.64% | 99,200 +6,200 | +7% | +$875K |
|
|
7
Biogen
BIIB
$19.4B
| $13.2M | 2.48% | 54,500 -22,040 | -29% | -$5.33M |
|
|
8
Gilead Sciences
GILD
$140B
| $13.1M | 2.46% | 156,500 -76,800 | -33% | -$6.41M |
|
9
Illumina
ILMN
$15.8B
| $12.9M | 2.42% | 91,575 -50 | -0.1% | -$7.02K |
|
10
Amgen
AMGN
$155B
| $12.7M | 2.39% | 83,500 -19,500 | -19% | -$2.97M |
|
11
Boston Scientific
BSX
$156B
| $11.7M | 2.2% | 500,000 | – | – |
|
12
Teva Pharmaceuticals
TEVA
$21.1B
| $11.5M | 2.17% | 229,190 +33,900 | +17% | +$1.7M |
|
13
Jazz Pharmaceuticals
JAZZ
$7.75B
| $10.6M | 2% | 75,300 +12,800 | +20% | +$1.81M |
|
14
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.5M | 1.97% | 30,000 -2,400 | -7% | -$838K |
|
15
Zimmer Biomet
ZBH
$21B
| $10.4M | 1.95% | 86,200 | – | – |
|
|
16
Becton Dickinson
BDX
$55.3B
| $10M | 1.88% | 59,000 -41,225 | -41% | -$6.99M |
|
|
CYTO
17
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $9.09M | 1.71% | 2,169,625 | – | – |
|
18
Ligand Pharmaceuticals
LGND
$3.15B
| $8.47M | 1.59% | 71,030 -10,800 | -13% | -$1.29M |
|
19
Centene
CNC
$14.3B
| $8.38M | 1.58% | 117,380 +11,500 | +11% | +$821K |
|
|
20
Hologic
HOLX
$14.9B
| $8.25M | 1.55% | 238,300 +157,300 | +194% | +$5.44M |
|
|
AGN
21
DELISTED
Allergan plc
AGN
| $8.11M | 1.53% | +35,100 | New | +$8.11M |
|
22
Intuitive Surgical
ISRG
$170B
| $7.94M | 1.49% | 12,000 -1,000 | -8% | -$661K |
|
23
CVS Health
CVS
$92.8B
| $7.64M | 1.44% | 79,800 -6,400 | -7% | -$613K |
|
24
Baxter International
BAX
$12.7B
| $7.51M | 1.41% | 166,000 +36,000 | +28% | +$1.63M |
|
25
Incyte
INCY
$16.5B
| $7.28M | 1.37% | 91,000 | – | – |
|